CLSA President & CEO Mike Guerra recently sat down with Global Business Reports to discuss CLSA’s mission, as well as the commitment of our members in helping patients, while boosting investment, innovation and job creation in California’s life sciences sector.
CLSA had a chance to speak with STAT News regarding medical research community concerns with AB889, a bill that would threaten the safety of researchers and discovery of new medicines. Check out Rebecca Robbins’ interview with Oliver Rocroi, CLSA’s VP, State Government Relations.
CLSA was recently featured in the news voicing concerns with a newly proposed California law (AB 889) that would add duplicative and burdensome reporting requirements for medical researchers who utilize animal models for testing throughout the Golden State.
CLSA’s hire of Andrew Setikas was recently featured in BioSpace’s Movers & Shakers list.
CLSA was recently featured in BioSpace regarding the Association’s 2018 Life Sciences Champions awards that took place in Sacramento.
CLSA was recently featured in the San Diego Business Journal regarding the expansion of its board.
Assemblyman Rob Bonta, Co-Chair of the California Legislative Rare Disease Caucus, pens an op-ed in The Sacramento Bee on the need to raise awareness and help California develop strong public policies to streamline the drug development pipeline and ensure that everyone with a rare disease gets the treatment they deserve.
CLSA recently spoke with STAT News regarding the potential impact of wildfire smoke on life science filtration systems and more.
CLSA recently spoke with the San Diego Business Journal regarding the impact of the partial government shutdown on the life sciences sector.
CLSA’s 2019 California Life Sciences Industry Report was recently profiled in BioSpace on the strength of San Diego’s life science cluster.